MORE NEWS

APLA Sustainability Virtual Meeting 2021

Peru

Mexico

Petrochemicals & Chemicals

Chile

Brazil

Argentina

September 19, 2021

APLA is organizing the first Latin America Sustainability Meeting to be held on September 28th on a virtual platform.

In this event, will be exposed the challenges faced by the diverse actors of the value chain in the region, while adapting the United Nations Sustainable Development Goals.

In this context, the “Sustainability Virtual Meeting” by APLA, the Latin American Petrochemical and Chemical Association, presents a 1-day agenda, that will address thematic axes about circular economy programs that will lead to sustainable business over time, the monitoring of public policies and the adaptation of global objectives to local realities reported by diverse regional actors.

The event will be held in a 100% virtual environment, and without cost.

Check the schedule and register for free here: https://web.cvent.com/event/2e2e90ee-fdcd-4116-8c29-9e0af0023a6f/summary

INTERVIEWS MORE INTERVIEWS

Dan Vujcic

CEO, SOLGOLD

"Ecuador has placed a lot of hope in this asset due to its size and its potential to unlock economic."

"Our exploration program for the next four years represents a comprehensive approach to hydrocarbon discovery across Angola's diverse geological provinces."

MINISTER OF NATURAL RESOURCES, GOVERNMENT OF NEW BRUNSWICK

"By targeting committed investors and maintaining strong regulatory and Indigenous relations, the province hopes to accelerate responsible mineral development and establish itself as a serious, results-oriented jurisdiction."

Mining

Canada

Peter Hagen

CEO, ALGOA CABINDA FABRICATION SERVICES

"There is still a lot of work in Cabinda, especially with ageing fields that require ongoing maintenance and the potential for new developments."

Oil & Gas

South Africa

Energy

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

MORE PREVIOUSLY PUBLISHED